SJMprofessional.com
1. Percutaneous occlusion of the left atrial appendage in non-valvular atrial fibrillation for the prevention of thromboembolism. National Institute
for Health and Clinical Excellence.
. Published June 2010.
Accessed April 2011.
Product referenced is approved for CE Mark. AMPLATZER, ST. JUDE MEDICAL and the nine-squares symbol are trademarks and service marks
of St. Jude Medical, Inc. and its related companies. ©2013 St. Jude Medical. All Rights Reserved.
An Alternative Therapy
for Reducing the Risk
of Stroke in Patients
with Atrial Fibrillation
1
AMPLATZER
™
Cardiac Plug
Structural Heart Therapy
Current evidence suggests that percutaneous occlusion of the left atrial appendage (LAA) is
efficacious in reducing the risk of thromboembolic complications associated with non-valvular atrial
fibrillation.
1
The AMPLATZER Cardiac Plug offers secure placement in a shallow landing zone and
positional forgiveness with a self-orienting disc. It is designed for a complete seal of the LAA.
